211 related articles for article (PubMed ID: 12171682)
1. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
Hagman JH; Carrozzo AM; Campione E; Romanelli P; Chimenti S
J Dermatolog Treat; 2001 Mar; 12(1):19-22. PubMed ID: 12171682
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.
de Zwaan SE; Iland HJ; Damian DL
Australas J Dermatol; 2009 Feb; 50(1):56-9. PubMed ID: 19178495
[TBL] [Abstract][Full Text] [Related]
3. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.
Charles CA; Leon A; Banta MR; Kirsner RS
Int J Dermatol; 2007 Oct; 46(10):1095-9. PubMed ID: 17910724
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pyoderma gangrenosum with intravenous immunoglobulin.
Cummins DL; Anhalt GJ; Monahan T; Meyerle JH
Br J Dermatol; 2007 Dec; 157(6):1235-9. PubMed ID: 17916196
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum.
Haag CK; Ortega-Loayza AG; Latour E; Keller JJ; Fett NM
J Dermatolog Treat; 2020 Nov; 31(7):723-726. PubMed ID: 30998080
[No Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
7. A novel therapy for the treatment of pyoderma gangrenosum.
Azizan NZ; Gangaram HB; Hussein SH
Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
[TBL] [Abstract][Full Text] [Related]
9. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy.
Zhang XB; He YQ; Zhou H; Luo Q; Li CX
Chin Med J (Engl); 2006 Jul; 119(14):1230-2. PubMed ID: 16863619
[No Abstract] [Full Text] [Related]
10. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin.
Dirschka T; Kastner U; Behrens S; Altmeyer P
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):789-90. PubMed ID: 9810896
[No Abstract] [Full Text] [Related]
13. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK; Rhodes JR; Evans B; Holt PJ
J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
[TBL] [Abstract][Full Text] [Related]
15. Pyoderma gangrenosum with necrotizing sclerokeratitis after cataract surgery.
Fournié P; Malecaze F; Coullet J; Arné JL
J Cataract Refract Surg; 2007 Nov; 33(11):1987-90. PubMed ID: 17964412
[TBL] [Abstract][Full Text] [Related]
16. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
[TBL] [Abstract][Full Text] [Related]
17. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
18. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial.
Reynoso-von Drateln C; Perla-Navarro AV; Gamez-Nava JI; Gonzalez-Lopez L; Galvan-Villegas F; Ramos-Remus C
J Rheumatol; 1997 Apr; 24(4):689-93. PubMed ID: 9101503
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum.
Nguyen JK; Holmes Z; Kelly RI
Australas J Dermatol; 2023 May; 64(2):221-228. PubMed ID: 36961092
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab.
Swale VJ; Saha M; Kapur N; Hoffbrand AV; Rustin MH
Clin Exp Dermatol; 2005 Mar; 30(2):134-6. PubMed ID: 15725238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
